Login

ICTR-PHE 2014

10–14 Feb 2014
Centre International de Conferences de Geneve (CICG)
Europe/Zurich timezone

Support

Vimentin (EMT Marker Protein) Score As One of Predictors Resistance to Erlotinib and Radiotherapy for Patients with Stage III Non-Small Cell Lung Cancer on A Prospective Phase II Trial

13 Feb 2014, 15:45
10m
Room 3

Room 3

Speaker

Ritsuko Komaki

Presentation materials

Powered by Indico v3.3.7-pre